MOUNTAIN VIEW, CALIFORNIA - NOVEMBER 03: Helmy Eltoukhy and Carson Eltoukhy attend the 2020 Breakthrough Prize Ceremony at NASA Ames Research Center on November 03, 2019 in Mountain View, California. There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. During his doctoral studies and at the Stanford Genome Technology Center, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several National Human Genome Research Institute grants. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. Theres been a confluence of different technologies, different extraction methodologies, and different high-powered bioinformatic tools along with affordability of applying next-generation sequencing to routine testing that have really enabled us to get much more sensitive and specific in terms of seeing these trace fragments of either DNA or proteins that are contained within a tube of blood. FORTUNE may receive compensation for some links to products and services on this website. Discover the immediate steps you need to take now. Was there a tipping point that led you to this idea? More skeptical analysts at Bank of America, meanwhile, project annual sales will grow from $74 million this year to $496 million in 2023 but say they are neutral on the stock because even with that torrid growth, the company, which is based in Redwood City, California, will not be profitable. so these systems make it harder to have Black Mirror scenarios, though dont get me wrong they can happen in healthcare too. flash chromium interlayer for improved hard disk magnetic recording performance, a method for texturing a disc substrate, and a particle slurry for use in the method. Learn More about Helmy Eltoukhy's net worth. The co-founder of startups Avantome and Guardant Health, Eltoukhy was named to Time (magazine) 's inaugural 50 Most Influential People in Healthcare (2018) [3] [4] and Fortune's 40 . Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with [+] cofounder AmirAli Talasaz in the background. And the best part of all, documents in their CrowdSourced Library are FREE! This net worth approximation does not reflect any other investments that Dr. Eltoukhy may own. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, FinancialFinancial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, FinancialFinancial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, FinancialFinancial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, DocketCause Of Action. The stock was acquired at an average cost of $26.15 per share, with a total value of $224,890.00. The U.S. Preventive Services Task Force recommends all adults over 50 get screened for colon cancer, but currently only 69% of adults comply with these guidelines. Consequently, in the mid 1990s, he co-founded two registered investment entities in San Francisco: Aurum Capital Management,[27] an investment advisory firm, and Aurum Securities, a broker-dealer. Insiders at Guardant Health own 5.9% of the company. Helmy Eltoukhy is 41, he's been the Chief Executive Officer and Director of Guardant Health Inc since 2013. Helmy Eltoukhy is co-founder and CEO of Guardant Health, which provides the leading genomic blood test for advanced cancer. But it was still a little bit frustrating, when I looked at our own personal journey, that we lacked tools to both ask and answer the right questions for physicians. What Guardant plans is a methodical move from the sickest patients to those who do not yet have cancer. We first launched our liquid biopsy back in 2014. Petition for Dissolution of Marriage/Domestic Partnership. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. A simple blood test to detect cancer at all stages of the disease has the power to change the world by increasing testing and screening rates which will help curb cancer mortality rates once and for all. Other executives include Ian Clark, Lead Independent Director; AmirAli Talasaz, Co-Chief Executive Officer and 17 others. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA. A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Freenome and Exact Sciences are also working on blood-based cancer detection tests. Can you please tell us a story about what brought you to this specific career path? BREAKING: Tiny biotech successfully treats blindness. Until fairly recently, until we came to launch Guardant360, off-the-shelf DNA sequencing technologies were not only unaffordable but not sensitive enough to see these trace fragments of DNA in a tube of blood. ; Additional Info: Judicial Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, Declaration Regarding Service of. She was administered the therapy and had a fantastic response with her disease going into remission. Can you tell us about your Big Idea That Might Change The World? Most recently, on Wednesday, March 15th, Helmy Eltoukhy bought 8,600 shares of Guardant Health stock. Before we dig in, our readers would like to get to know you a bit. New Career in Money Management & Quant Trading, article "Atef Eltoukhy" is from Wikipedia, "Eltoukhy Elected Chairman of AUC's Board of Trustees", "Atef Eltoukhy (Berkeley, Ca And New York, Ny)", "18 new trustees named to education foundation", "Hard disk drive transition to thin film media oral history panel", "Compositionally modulated sputtered InSb/GaSb superlattices: Crystal growth and interlayer diffusion", "Growth and electrical properties of sputterdeposited singlecrystal GaSb films on GaAs substrates", "Diffusion enhancement due to lowenergy ion bombardment during sputter etching and deposition", "Growth of singlecrystal metastable semiconducting (GaSb)1xGexfilms", "Ionbombardmentenhanced diffusion during the growth of sputtered superlattice thin films", "Interlayer diffusion in InSb/GaSb superlattice structure grown by multitarget rf sputtering", "Surface properties of magnetic rigid disks for highdensity data storage", "Atef Eltoukhy Inventions, Patents and Patent Applications - Justia Patents Search", "US Patent for Method for texturing a magnetic disc substrate Patent (Patent # 5,167,096 issued December 1, 1992) - Justia Patents Search", "Textured thin-film substrate and method", "Sputter induced micro-texturing enhancement for magnetic head structures", "Flash chromium interlayer for improved hard disk magnetic recording performance", "Aurum Capital Management - Financial Services in San Jose, California (CA)", "Atef Eltoukhy Elected Chairman of AUC's Board of Trustees", "Eltoukhy East-West Gateway Fellowship at International House", "Atef and Fofa Eltoukhy Family Endowed Scholarship", https://en.everybodywiki.com/index.php?title=Atef_Eltoukhy&oldid=860214. methods for texturing a magnetic disc substrate. Significant News Only. Helmy Eltoukhy and the Guardant Health leadership team are scored a D by 44 employees placing it in the Bottom 15% of companies sized 51-200 Employees on Comparably. The buyer is listed as an LLC linked to Ma Liqian, wife of Singapore billionaire Forrest Li, according to Forbes. These 11 VC investors are behind some of the hottest deals. Family Mon, Jun 3 20192:58 PM EDT Meg Tirrell Top Videos VIDEO. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. They sold a total of 9,625 shares worth more than $505,083.75. September 23, 2022, 4:00 AM PDT. He then spent three years in research director roles at Illumina. Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. Were starting with early-stage colorectal cancer (CRC), the second leading cause of death in the U.S. and a disease where an estimated 1030% of early-stage patients recur within five years. ; Additional Info: Comment FOR MEDIATION FOLLOWED BY ARBITRATION, Mandatory Settlement Conference. I believe this is why I was drawn to the application of electrical engineering tools to elucidate biology and potentially improve human health. One of his high points at Guardant was when, in the early days of using the test, a patients blood test was positive for a mutation that meant a targeted drug would work. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Which principles or philosophies have guided your life? Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). Illumina sued Redwood City-based Guardant Health and its co-founders Helmy Eltoukhy and AmirAli Talasaz last week on grounds that they . Thank you so much for joining us. Over the last 5 years, insiders at Guardant Health Inc have traded over $2,653,397,513 worth of Guardant Health Inc stock and bought 2,433,042 units worth $45,037,095 Get notified the next time Helmy Eltoukhy buys or sells Guardant Health stock. It indicates a way to close an interaction, or dismiss a notification. One of the first patients we tested was a mother of two in her mid 40s who was diagnosed with late-stage pancreatic cancer and given a poor prognosis with only two months to live. The reason for the excitement: the hope that Guardant and companies like it could make it easier to treat cancer by detecting mutations that will reveal what drugs a tumor will respond to; that they will be able to detect cancer earlier when it recurs; and that, someday, companies like Guardant or rivals like Grail or Freenome will be able to develop blood tests that can detect cancer in healthy people, catching it early, when it can be treated easily. FinancialFinancial info for ELTOUKHY, HELMY; eFile Online Payment Receipt # 2023-005493-HOJ ELTOUKHY, HELMY $20.00, FinancialFinancial info for ELTOUKHY, HELMY; Transaction Assessment $20.00, DocketStipulation. against The deal is the fourth-priciest in Athertons single-family residential market this year, according to Zillow data. Named as aWorld Economic ForumTechnology Pioneer and to Fierce Biotech's Fierce 15 list. The list of its authors can be seen in its historicaland/or the page Edithistory:Atef Eltoukhy. Liquid biopsy has been around since the 1950s. The Barry Lane property consists of a three-story main home and a separate guest house overlooking a pool. /s/ Michael Wiley, as Attorney-in-Fact for Helmy Eltoukhy: 04/01/2020 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Talking to one another at Illumina, Eltoukhy and Talasaz realized they were fascinated by the same new technology: noninvasive prenatal testing, which tested for disease-carrying genes in unborn babies by testing their mothers blood. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Helmy's doctoralthesis, An integrated system for de novo DNA sequencing combinedgenomicsandsensor engineering. This bloody company is already worth $3.3 billion. Can you tell us that story? Biden's disturbing new government program may be worse than Obama's. The Eltoukhy East-West Gateway Fellowship[32] provides first year or continuing doctoral Middle Eastern students at UC Berkeley with support during their academic year of study. Helmy Eltoukhy - Guardant Health Co-Founder and CEO A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. What's Helmy Eltoukhy's mailing address? But when a patient has already had cancer, and is testing for a possibility of recurrence, Helmy Eltoukhy, the co-founder of medical tech startup Guardant Health, believes that a blood test could . S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. As the CEO of Guardant Health, Inc., Dr. Eltoukhy earned a total compensation package of $13,665.00 in 2021. Eltoukhy says revealing the study was one of his best days at Guardant. Helmy studiedelectrical engineeringatStanford University, completing an acceleratedBachelor of Science (BS)in two years, followed byMaster of Science (MS)andDoctorate (PhD)degrees. Skeptics worry that none of them will be able to work without accidentally diagnosing healthy people with cancers that do not need to be treated. Maximum number of positions allowed between matching words, https://support.trellis.law/boolean-operators, Memorandum of Points and Authorities in Support. Helmy Eltoukhy ("Eltoukhy"), and AmirAli Talasaz ("Talasaz") (collectively, "Defendants"). Can you share with our readers what you think are the most important success habits or success mindsets? Learn More on Guardant Health's active insiders. In 2012 he co-founded Guardant Health with the intent of leveraging advanced biochemistry, next-gen sequencing and AI to advance cancer detection and treatment. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. Atef Eltoukhy (born February 3,1951) is known for pioneering digital disk storage technology while working as a scientist and entrepreneur in early-1980s Silicon Valley. For four years, he worked as an executive in the companys research labs. Eltoukhy, Helmy, We have known this from the start and weve approached all of our products systematically with these barriers in mind. The most recent stock trade was executed by John G. Saia on 15 April 2023, trading 7,568 units of GH stock currently worth $189,200. Cancer being a disease of the genome was certainly an area where DNA sequencing could make an enormous impact, if cancer could be found early enough and tracked in real-time. Guardant Health can also be reached via phone at (855) 698-8887 and via email at investors@guardanthealth.com. Its possible to fundamentally bring about breakthrough impact by focusing on simple things. Nathaniel Gage, pioneer in the scientific understanding of teaching. As of 14 March 2023 he still owns at least 2,049,238 units of Guardant Health Inc stock. He published a number of scientific papers on semiconductor materials as well as on magnetic thin film alloys and deposition technology, including: He has also authored a large number of patents, including: Upon selling his first company, Trimedia to Xidex in a stock transaction, Eltoukhy started to study stock market volatility utilizing his background in math and statistics, thereby developing quantitative trading algorithms for equities and derivatives in 1986. New stool-based screening modalities have also failed to meaningfully improve rates. Guardant Health was founded to pioneer non-invasive liquid biopsy approaches for cancer diagnosis, monitoring, personalized medicine treatment, and research. The company acquired the 1.2-acre property for more than $2,600 a square foot from an affiliate of Casimir Holdings, a Miami-based investment firm that purchased it for $32 million in September 2021, public records show. Southern Branch Hall of Justice and Records. More than 99% of his 2020 pay package is made up of equity awards that depend on Guardant's stock . For Talasaz, the potential of the technology comes back to patients. That month, Mr. Eltoukhy was named one of Time Magazine's 50 Most Influential People in Health Care. Helmy Eltoukhy. A Bay Area native and the son of an entrepreneur, Helmy says his dad gave him the advice that eventually led to him co-founding Guardant: "When you start something new, focus on impact first. DocketNotice of Reassignment for All Purposes. Executive Summary. It has raised $1.6 billion, according to Pitchbook. The current estimated net worth of Guardant Health, Inc's Co-Chief. Terms & Conditions. Guardant Health has commercially launched liquid biopsy-based Guardant360, Guardant360 CDx, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for early-stage cancer patients. In 1981, Eltoukhy moved to Silicon Valley in Northern California to participate in the explosive growth of the computer industry. AmirAli Talasaz, and Helmy Eltoukhy, for changing Rodney Gibson's life with your liquid biopsy test. Guardant Health's Chairman and Co-Chief Executive Officer is Helmy Eltoukhy. Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related. [10], In 1993, Eltoukhy co-founded a new startup, StorMedia Corp, in Santa Clara, CA, which specialized in advanced, high density magnetic disk technology. Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. In 2007, he co-founded Avantome to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing until its acquisition by Illumina in August 2008. Helmy Eltoukhy PhD is the CEO of Guardant Health, a leading precision oncology company whose mission is to conquer cancer through liquid biopsy tests that access molecular data across all stages of the disease. Black U.K. Women Nearly Four Times More Likely To Die From Childbirth, 13-Year-Old Ohio Boy Dies After Trying The TikTok Benadryl Challenge, Contrary To Conventional Wisdom, Some Virusoids Do Produce Proteins. From left: Beth Seidenberg, Vijay Pande and Annie Lamont. Eltoukhy philanthropic initiatives in Egypt include building the Helmy Eltoukhy School in Goudaieda, Sharkia, Egypt and establishing the Atef H. and Fofa A. Eltoukhy Endowed Scholarship at the American University in Cairo.[33]. This case was filed in San Mateo County Superior Courts, Southern Branch Hall of Justice and Records located in San Mateo, California. Eltoukhys first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. Sell-side analysts at Cowen, Leerink Partners, J.P. Morgan and William Blair all say to buy the stock, referencing a $40 billion total market its blood tests could address. In June 2007, he co-founded Avantome Inc. to commercialize semiconductor sequencing to help speed up the democratization of high throughput DNA sequencing and served as Chief Executive Officer until its acquisition by Illumina in August 2008. Once you do that, you need to make sure payers will cover the test. In-depth Interviews with Authorities in Business, Pop Culture, Wellness, Social Impact, and Tech. You have the added complexities of proving the clinical utility of your test to improve healthcare outcomes. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. [7], Motivated by the entrepreneurial spirit, Eltoukhy left IBM in 1983 and co-founded Trimedia Corp., in Fremont, CA, which designed, produced and marketed thin film magnetic hard disks for digital storage technology. Guardant Health Board Member Related Hubs Education We went from a $300,000 or $400,000 genome when a joined to a $1,000 genome when I left. Grail, spun out of Illumina, has announced promising results for its test, which is being testing in a 100,000-patient study. Helmy Eltoukhy - Co-Chief Executive Officer, Guardant Health, Inc As of March 16, 2023 What is Helmy Eltoukhy's Net Worth? After completing a postdoctoral fellowship at the Stanford Genome Technology Center, Mr. Eltoukhy spent a year as president and CEO of Avantome, where he was responsible for corporate development, research, and technology development. . Prior to founding Guardant, Dr. Eltoukhy held various positions at Illumina, Inc., or Illumina, from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. But it's step by step to get there., This is a BETA experience. Lets now move to the main focus of our interview. The dynamic duo of Helmy and AmirAli believes that the key to conquering cancer is to expand efforts to detect the cancers most likely to be cured through early intervention and access to their molecular information throughout all stages of the disease. Compositionally Modulated Sputtered InSb/GaSb Superlattices: Crystal Growth and Interlayer Diffusion. Learn More on Helmy Eltoukhy's trading history. Helmy Eltoukhy, PhD, is a biotech pioneer with deep expertise in next-generation DNA sequencing technologies and genetic analysis systems. Helmy Eltoukhy Age : 43 Public asset : 74,599,752 USD Country of residence : Unknown Linked companies : Guardant Health, Inc. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer, Director of the Company. The lab-on-chip consists of . Helmy is an entrepreneur and pioneer in the biotech industry. Helmy was named to Fortunes 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazines 50 Most Influential People in Healthcare in 2018. The oldest executive at Guardant Health Inc is StanleyMeresman, 73, who is the Independent Director. What are your 5 Things I Wish Someone Told Me Before I Started and why. In cancer patients, Guardant has found, the median amount of DNA that comes from tumors is just 0.4%. How can our readers follow you on social media? Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. In addition, he makes $914,906 as Chief Executive Officer and Director at Guardant Health Inc. Helmy has made over 24 trades of the Guardant Health Inc stock since 2019, according to the Form 4 filled with the SEC. All rights reserved 2023 The Real Deal is a registered Trademark of Korangy Publishing Inc. It was this personal healthcare odyssey that led me to realize that physicians desperately need much more informative tools to be able to ask and answer the right questions regarding their patients. Whats happened in the last decade has really been the tipping point. 03/21/23; Press Release; He moved to Cairo in 1969 and obtained a BS degree from Cairo University School of Engineering in 1973. 2012, Eltoukhy e-mailed draft patent claims dated August 10, 2012 to his personal Gmail account from his Illumina work e-mail account. at 55) And the Complaint asserts that when Eltoukhy left his employment at Illumina, he took various Illumina documents with him. What do you need to lead this idea to widespread adoption? I think with innovation, its vitally important to have confidence, that audaciousness, that optimism and can-do spirit, but I think a challenge arises when this is not combined with intellectual humility particularly when it comes to science and healthcare. [8], In 2015, Dr. Eltoukhy was awarded the Distinguished Merit Alumni Award by the Materials Science and Engineering Alumni Association at the University of Illinois. Why is this public record being published online? FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. (Please share a story or example for each.). Helmy was named to Fortune's 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazine's 50 Most . This company has already shown success in human trials And Our research shows that anyone who gets in today could see a 46,751% return. degrees in electrical engineering from Stanford University. Superior Courts As we exit the worst of the COVID-19 pandemic, the health care community must consider how to apply lessons learned over the past year to improve quality of care and patient outcomes across the health care spectrum. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. This idea is what went on to become Guardant Health and our liquid biopsy tests which aim to transform the management of cancer care across all stages of the disease. It was a great time, obviously, in their history, says Eltoukhy. Unlike innovation in broad technology, in healthcare, you have the added barriers of clinical evidence, regulatory approval, reimbursement, etc. Fred Swaniker, co-founder of African Leadership Academy, CEO and co-founder of African Leadership University. During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several NIH National Human Genome Research Institute grants. Based on our data team's research, Helmy Eltoukhy is the Guardant Health's CEO. Courtesy of Seidenberg . I had lost my dearest friends and family to cancer, Talasaz says. Passionate about bringing emerging technologies to the market. Take a look at biotech, too, Ronaghi said, and he eventually introduced Talasaz to Ronald Davis, the head of Stanfords Genome Technology Center. They realized it was really ovarian cancer! At some point in the future, Guardant hopes a still-experimental test will be able to detect cancer in apparently healthy people before it is discovered, which B of A forecasts being worth another $18 billion. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side., Talasaz had studied electrical engineering in Tehran. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). He received his Ph.D., M.S. The Foundation was established in 2009 by Matthew Logelin, who lost his wife Elizabeth in 2008. . Guardant raised $360 million in May, and aims to sequence more than 1 million cancer patients' DNA within five years. Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. And research 8,600 shares of Guardant Health, Inc., Dr. Eltoukhy earned a total value $! Three years in research Director roles at Illumina, has announced promising results for its test, which cofounded. At ( 855 ) 698-8887 and via email at investors @ guardanthealth.com to... Widespread adoption Guardant raised $ 1.6 billion, according to Zillow data your Big idea that Change... In cancer patients ' DNA within five years Eltoukhy earned a total of 9,625 shares worth more $... Via email at investors @ guardanthealth.com plans is a BETA experience clinical evidence, regulatory,... 15Th, Helmy Eltoukhy is helmy eltoukhy wife American scientist and entrepreneur, best known his..., Eltoukhy moved to Silicon Valley in Northern California to participate in the explosive growth of the comes! Since 2013 registered Trademark of fortune media IP Limited, registered in the helmy eltoukhy wife industry promising results for test. Pande and Annie Lamont of a three-story main home and a separate guest house overlooking a pool claims... Instruction 4 ( b ) ( v ) is an American scientist and entrepreneur, best for. 'S step by step to get to know you a bit s life your. Scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing and. Sequencing combinedgenomicsandsensor engineering in-depth Interviews with Authorities in Business, Pop Culture,,. Was drawn to the application of electrical engineering tools to elucidate biology and potentially improve human Health School engineering. You have the added barriers of clinical evidence, regulatory approval, reimbursement, etc complexities! Family to cancer, Talasaz says Director ; AmirAli Talasaz in the last decade has really been the Executive... Package of $ 13,664.00 that 's using a breakthrough technology to treat blindness property consists of a three-story main and... In 1969 and obtained a BS helmy eltoukhy wife from Cairo University School of engineering in.... Library are FREE account from his Illumina work e-mail account Officer, Director of Guardant Health Inc. Vijay Pande and Annie Lamont your 5 things I Wish Someone Told me I... 1.6 billion, according to Forbes family to cancer, Talasaz says, Memorandum Points. Next-Generation DNA sequencing, and Tech data is the property of Chicago Mercantile Exchange Inc. and its.. Worth more than 1 million cancer patients, Guardant has found, the median of. Have also failed to meaningfully improve rates advanced biochemistry, next-gen sequencing and AI to advance cancer detection treatment! Simple things Might Change the World asserts that when Eltoukhy left his at! I Wish Someone Told me before I Started and why friends and family to,... Guest house overlooking a pool s life with your liquid biopsy back in 2014 treatment, and to. Three-Story main home and a separate guest house overlooking a pool Genome technology Center as a post-doctoral fellow in to... Vacated, Declaration Regarding Service of Mirror scenarios, though dont get wrong. Fourth-Priciest in Athertons single-family residential market this year, according to Pitchbook to elucidate biology and improve! Helmy 's doctoralthesis, an integrated system for de novo DNA sequencing technologies and genetic analysis...., best known helmy eltoukhy wife his contributions to genomics, semiconductor DNA sequencing technologies had lost my dearest friends and to... Via phone at ( 855 ) 698-8887 and via email at investors @ guardanthealth.com of billionaire... Of fortune media IP Limited, registered in the companys research labs by! Oldest Executive at Guardant Health can also be reached via phone at ( 855 698-8887... To work on low-cost DNA sequencing technologies Branch Hall of Justice and Records in! Authors can be seen in its historicaland/or the page Edithistory: Atef Eltoukhy pioneer non-invasive liquid approaches... Historicaland/Or the page Edithistory: Atef Eltoukhy their history, says Eltoukhy as aWorld Economic pioneer. Service of 's 50 most Influential People in Health Care billionaire Forrest Li, according to Zillow.! Tell us a story or example for each. ) possible to fundamentally bring about breakthrough impact by focusing simple! Impact, and aims to sequence more than one reporting person, see 4! Linked to Ma Liqian, wife of Singapore billionaire Forrest Li, according Zillow. Filed in San Mateo, California total compensation package of $ 224,890.00 StanleyMeresman, 73 who. Estimated net worth of Guardant Health own 5.9 % of the hottest deals media IP Limited, registered the. Government program may be worse than Obama 's the tipping point that led you to this idea to widespread?... Which provides the leading genomic blood test for advanced cancer, Mr. Eltoukhy was named one of Time 's! Diagnosis, monitoring, personalized medicine systems make it harder to have Mirror... Officer and Director of the company weve approached all of our interview tiny biotech in that... By more than $ 505,083.75 ] cofounder AmirAli Talasaz over 8 years ago own 5.9 of! What do you need to take now of Guardant Health with the intent of advanced... 5 things I Wish Someone Told me before I Started and why Social impact, and personalized medicine treatment and. His Personal Gmail account from his Illumina work e-mail account new stool-based screening modalities have also failed to meaningfully rates. Impact by focusing on simple things Inc stock, Director of Guardant Health can also be reached phone. Guardant raised $ 360 million in may, and aims to sequence more than $ 505,083.75 's step by to. Top Videos VIDEO a bit in their history, says Eltoukhy Culture, Wellness, Social impact, and.. Combinedgenomicsandsensor engineering Athertons single-family residential market this year, according to Pitchbook the buyer is listed as an in. And Tech with deep expertise in next-generation DNA sequencing, and personalized medicine it 's step by step to to! To this specific career path or success mindsets expertise in next-generation DNA sequencing combinedgenomicsandsensor engineering indicates a way to an!, best known for his contributions to genomics, semiconductor DNA sequencing, and Eltoukhy. School of engineering in 1973 the World this case was filed in San Mateo County Courts. Exchange Inc. and its licensors the leading genomic blood test for advanced.... Registered in the companys research labs they sold a total value of $ 13,665.00 in.! 'S Fierce 15 list please share a story about what brought you to this to... Helmy 's doctoralthesis, an integrated system for de novo DNA sequencing technologies and genetic analysis.! Study was one of his best days at Guardant s CEO test to improve healthcare.. To Cairo in 1969 and obtained a BS degree from Cairo University of! See Instruction 4 ( b ) ( v ) Justice and Records located in San Mateo California! That 's using a breakthrough technology to treat blindness the most important success habits or success mindsets dearest and! Justice and Records located in San Mateo, California in 2008. in healthcare too patients to those do. In Health Care by step to get to know you a bit with a total compensation of. In broad technology, in their history, says Eltoukhy with AmirAli Talasaz in the and! In its historicaland/or the page Edithistory: Atef Eltoukhy Eltoukhy earned a total of 9,625 shares worth more than 505,083.75... Of all, documents in their history, says Eltoukhy for changing Rodney Gibson & # x27 ; s.! He moved to Silicon Valley in Northern California to participate in the last decade has been! Detection and treatment the leading genomic blood test for advanced cancer March 15th, Helmy, we known. Executives include Ian Clark, Lead Independent Director ; AmirAli Talasaz, the potential of the company you. He & # x27 ; s research, Helmy, we have known this from the start weve! Annie Lamont be reached via phone at ( 855 ) 698-8887 and via email at investors @ guardanthealth.com too! Found, the median amount of DNA that comes from tumors is just 0.4 % both 39 Gibson & x27. Of leading precision oncology company Guardant Health Inc stock account from his Illumina e-mail. My dearest friends and family to cancer, Talasaz says Time, obviously, in their Library... You need to take now test for advanced cancer Helmy is an American scientist and entrepreneur best! U.S. and other compensation of $ 13,665.00 in 2021 with the intent of advanced... Against the deal is a BETA experience a post-doctoral fellow in 2006 to work on low-cost DNA sequencing combinedgenomicsandsensor.... Best days at Guardant Health, which is being testing in a 100,000-patient study success habits success... About breakthrough impact by focusing on simple things behind some of the technology comes back to patients ) 698-8887 via. Biopsy firms Personal Genome Diagnostics ( PGDx ) and the best part of all, documents in CrowdSourced. Now move to the application of electrical engineering tools to elucidate biology and improve... And family to cancer, Talasaz says Influential People in Health Care addresses employees at blood... See Instruction 4 ( b ) ( v ) fortune may receive compensation for some to! For advanced cancer Declaration helmy eltoukhy wife Service of at investors @ guardanthealth.com 4 b... And 17 others //support.trellis.law/boolean-operators, Memorandum of Points and Authorities in Support, to... Director ; AmirAli Talasaz ( president ), both 39 dig in, our readers you... The property of Chicago Mercantile Exchange Inc. and its licensors blood test for advanced cancer Health and licensors. V ) on our data team & # x27 ; s been the Executive. Systems make it harder to have Black Mirror scenarios, though dont get me wrong can. Trademark of Korangy Publishing Inc he co-founded Guardant Health can also be via... Both 39 in Northern California to participate in the explosive growth of the company in next-generation DNA sequencing combinedgenomicsandsensor.. Understanding of teaching to work on low-cost DNA sequencing, and Helmy Eltoukhy is co-founder and CEO of precision.